Stefan Proniuk Selected Research

onapristone

1/2018	Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
7/2015	A single-dose PK study of onapristone including the effect of food on absorption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Proniuk Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2018 - 07/2015
2	Neoplasms (Cancer) 01/2018 - 03/2016
2	Infections 12/2017 - 01/2017
1	Endometrial Neoplasms (Endometrial Cancer) 01/2018
1	Proteostasis Deficiencies 12/2017
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2017
1	Rubella (German Measles) 10/2016
1	Human Influenza (Influenza) 10/2016
1	Measles 10/2016
1	Mumps 10/2016
1	Prostatic Neoplasms (Prostate Cancer) 07/2015
1	Skin Neoplasms (Skin Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

2	onapristoneIBA 01/2018 - 07/2015
2	Proteins (Proteins, Gene)FDA Link 10/2016 - 03/2016
2	Endoplasmic Reticulum Chaperone BiPIBA 10/2016 - 03/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	PrionsIBA 12/2017
1	Antiviral Agents (Antivirals)IBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 10/2016
1	Viral ProteinsIBA 10/2016
1	Phosphotransferases (Kinase)IBA 03/2016
1	ThioredoxinsIBA 03/2016
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 03/2016
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2002
1	AntioxidantsIBA 01/2002

Therapy/Procedure

1	Duration of Therapy 01/2018